Pond GR - Search Results

1

Pharmacist medication assessments in a surgical preadmission clinic.

Kwan Y, Fernandes OA, Nagge JJ, Wong GG, Huh JH, Hurn DA, Pond GR, Bajcar JM. Kwan Y, et al. Among authors: pond gr. Arch Intern Med. 2007 May 28;167(10):1034-40. doi: 10.1001/archinte.167.10.1034. Arch Intern Med. 2007. PMID: 17533206 Clinical Trial.

2

Barriers in phase I cancer clinical trials referrals and enrollment: five-year experience at the Princess Margaret Hospital.

Ho J, Pond GR, Newman C, Maclean M, Chen EX, Oza AM, Siu LL. Ho J, et al. Among authors: pond gr. BMC Cancer. 2006 Nov 8;6:263. doi: 10.1186/1471-2407-6-263. BMC Cancer. 2006. PMID: 17092349 Free PMC article.

3

Correlation of changes between 2-year disease-free survival and 5-year overall survival in adjuvant breast cancer trials from 1966 to 2006.

Ng R, Pond GR, Tang PA, MacIntosh PW, Siu LL, Chen EX. Ng R, et al. Among authors: pond gr. Ann Oncol. 2008 Mar;19(3):481-6. doi: 10.1093/annonc/mdm486. Epub 2007 Nov 20. Ann Oncol. 2008. PMID: 18029973 Free article. Review.

4

Medication reconciliation at hospital discharge: evaluating discrepancies.

Wong JD, Bajcar JM, Wong GG, Alibhai SM, Huh JH, Cesta A, Pond GR, Fernandes OA. Wong JD, et al. Among authors: pond gr. Ann Pharmacother. 2008 Oct;42(10):1373-9. doi: 10.1345/aph.1L190. Ann Pharmacother. 2008. PMID: 18780806

5

Influence of an independent review committee on assessment of response rate and progression-free survival in phase III clinical trials.

Tang PA, Pond GR, Chen EX. Tang PA, et al. Among authors: pond gr. Ann Oncol. 2010 Jan;21(1):19-26. doi: 10.1093/annonc/mdp478. Epub 2009 Oct 29. Ann Oncol. 2010. PMID: 19875758 Free article.

6

"PSA-itis": knowledge of serum prostate specific antigen and other causes of anxiety in men with metaststic prostate cancer.

Lofters A, Juffs HG, Pond GR, Tannock IF. Lofters A, et al. Among authors: pond gr. J Urol. 2002 Dec;168(6):2516-20. doi: 10.1097/01.ju.0000032824.52830.55. J Urol. 2002. PMID: 12441952

7

Consistency in the analysis and reporting of primary end points in oncology randomized controlled trials from registration to publication: a systematic review.

You B, Gan HK, Pond G, Chen EX. You B, et al. J Clin Oncol. 2012 Jan 10;30(2):210-6. doi: 10.1200/JCO.2011.37.0890. Epub 2011 Dec 12. J Clin Oncol. 2012. PMID: 22162583 Review.

8

Sucralfate mouthwash for prevention and treatment of 5-fluorouracil-induced mucositis: a randomized, placebo-controlled trial.

Nottage M, McLachlan SA, Brittain MA, Oza A, Hedley D, Feld R, Siu LL, Pond G, Moore MJ. Nottage M, et al. Support Care Cancer. 2003 Jan;11(1):41-7. doi: 10.1007/s00520-002-0378-8. Epub 2002 Jul 23. Support Care Cancer. 2003. PMID: 12527953 Clinical Trial.

9

Gemcitabine concurrent with continuous infusional 5-fluorouracil in advanced biliary cancers: a review of the Princess Margaret Hospital experience.

Knox JJ, Hedley D, Oza A, Siu LL, Pond GR, Moore MJ. Knox JJ, et al. Among authors: pond gr. Ann Oncol. 2004 May;15(5):770-4. doi: 10.1093/annonc/mdh172. Ann Oncol. 2004. PMID: 15111345 Free article. Clinical Trial.

10

Long-term follow-up of secondary malignancies in adults after allogeneic bone marrow transplantation.

Hasegawa W, Pond GR, Rifkind JT, Messner HA, Lau A, Daly AS, Kiss TL, Kotchetkova N, Galal A, Lipton JH. Hasegawa W, et al. Among authors: pond gr. Bone Marrow Transplant. 2005 Jan;35(1):51-5. doi: 10.1038/sj.bmt.1704706. Bone Marrow Transplant. 2005. PMID: 15516939

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results